<DOC>
	<DOCNO>NCT03004963</DOCNO>
	<brief_summary>Peritoneal dialysis ( PD ) one establish treatment end stage renal disease patient . Volume overload predictor mortality PD patient . In Randomized control trial , investigator use Body Composition Monitor ( BCM ) , multifrequency bioimpedance device , measure level overhydration PD patient explore value fluid management peritoneal dialysis patient well prognosis .</brief_summary>
	<brief_title>Bioimpedance-guided Fluid Management Chronic Peritoneal Dialysis Patients .</brief_title>
	<detailed_description>Optimal fluid management one primary objective dialysis treatment , significant concern peritoneal dialysis ( PD ) patient become progressively fluid-loaded time treatment , especially residual kidney function decline . Body Composition Monitor ( BCM ) potential enable well management fluid balance . The investigator undertake prospective , randomize , open-label , controlled trial determine whether availability longitudinal BCM measure help clinician maintain stable fluid status 24 month 300 peritoneal dialysis patient .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Patients 18 year old old 80 year . chronic peritoneal dialysis 3 month . All sign inform consent . expect stop PD treatment 6 month ; amputee ; cardiac pacemaker metallic implant ; peritonitis one month recruitment ; treat together hemodialysis ; pregnancy lactation ; positive HIV ; serious disease , include cancer , infection liver cirrhosis , suitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Peritoneal Dialysis</keyword>
	<keyword>Volume Status</keyword>
	<keyword>Body Composition Monitor</keyword>
</DOC>